Emergency Medicine

HIV / AIDS

Medical News

Primary Care

Surgery

Home » Geriatrics, Tuberculosis

Anti-TNF Therapies Carry Varying Levels of TB Risk (CME/CE)

Submitted by MedicalReplies on Thursday, 2 July 2009No Comment

LITTLE FALLS, N.J. (MedPage Today) — The risk of tuberculosis is higher for patients receiving anti-tumor necrosis factor (anti-TNF) monoclonal antibody therapy than for those receiving soluble TNF receptor therapy for any indication, French researchers found.

Here is the original post:
Anti-TNF Therapies Carry Varying Levels of TB Risk (CME/CE)

You may also like:

Leave your response!

Add your comment below, or trackback from your own site. You can also subscribe to these comments via RSS.

Be nice. Keep it clean. Stay on topic. No spam.

You can use these tags:
<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

This is a Gravatar-enabled weblog. To get your own globally-recognized-avatar, please register at Gravatar.

*
To prove you're a person (not a spam script), type the security word shown in the picture.
Anti-spam image